Newer Agents for Rapid Sequence Intubation: Etomidate and Rocuronium

Pediatric Emergency Care

Volumn 25, Issue 3, 2009, Pages 201-211

  Ching, Kevin Y ^a   Baum, Carl R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etomidate; Induction agent; Neuromuscular blocking agent; Pediatric critical care; Rapid sequence intubation; Rocuronium; Sedating agent

Indexed keywords

CHOLESTEROL; ETOMIDATE; HYDROCORTISONE; KETAMINE; MIDAZOLAM; PROPOFOL; ROCURONIUM; STEROID 11BETA MONOOXYGENASE; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ADRENAL CORTEX; ADRENAL CORTEX INSUFFICIENCY; ADRENAL FUNCTION; BRAIN PROTECTION; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; EMERGENCY CARE; ENZYME INHIBITION; FASCICULATION; HEART ARREST; HEMODYNAMICS; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; INTUBATION; METABOLISM; MYOCLONUS; PARALYSIS; REVIEW; SEDATION; SEIZURE; SEPTIC SHOCK; SINGLE DRUG DOSE; TACHYCARDIA; VOMITING;

ANDROSTANOLS; ANESTHETICS, INTRAVENOUS; ETOMIDATE; HUMANS; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREMEDICATION;

EID: 66249119384     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31819a8bbf     Document Type: Review

References (85)

1. Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med. 1997;15:221-230.
2. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients [letter]. Lancet. 1983;1:1270.
3. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anaesthetic etomidate. N Engl J Med. 1984;310:1415-1421.
4. Allolio B, Dorr H, Stuttman R, et al. Effect of a single dose of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol. 1985;22:281-286.
5. Jacoby JL, Fulton J, Melanson S, et al. The emergent airway: what drugs and adjuncts do emergency physicians prefer? [letter]. Am J Emerg Med. 2004;22:325-326.
6. Sakles JC, Laurin EG, Rantapaa AA, et al. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med. 1998;31:325-332.
7. Sivilotti ML, Ducharme J. Randomized, double-blind study on sedatives and hemodynamics during rapid-intubation in the emergency department: the SHRED study. Ann Emerg Med. 1998;31:313-324.
8. Kay B. A dose-response relationship for etomidate, with some observations on cumulation. Br J Anaesth. 1976;48:213-216.
9. Zuckerbraun NS, Pitetti RD, Herr SM, et al. Use of etomidate as an induction agent for rapid sequence intubation in a pediatric emergency department. Acad Emerg Med. 2006;13:602-609.
10. Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med. 2006;13:378-383.
11. Smith DC, Bergen JM, Smithline H, et al. A trial of etomidate for rapid sequence intubation in the emergency department. J Emerg Med. 2000;18:13-16.
12. Sivilotti ML, Filbin MR, Murray HE, et al. Does the sedative agent facilitate emergency rapid sequence intubation? Acad Emerg Med. 2003;10:612-620.
13. Jacoby J, Heller M, Nicholas J, et al. Etomidate versus midazolam for out-of-hospital intubation: a prospective, randomized trial. Ann Emerg Med. 2006;47:525-530.
14. Guldner G, Schultz J, Sexton P, et al. Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events. Acad Emerg Med. 2003;10:134-139.
15. Leibowitz PW, Cote ME, Daniels AL, et al. Comparative cardiovascular effects of midazolam and thiopental in healthy patients. Anesth Analg. 1982;61:771-775.
16. Giese JL, Stockham RJ, Stanley TH, et al. Etomidate versus thiopental for induction of anesthesia. Anesth Analg. 1985;64:871-876.
17. Scheffer GJ, Ten Voorde BJ, Karemaker JM, et al. Effects of thiopentone, etomidate, and propofol on beat to beat cardiovascular signals in man. Anaesthesia. 1993;48:849-855.
18. Grounds RM, Twigley AJ, Carli F, et al. The hemodynamic effects of intravenous induction: comparison of effects of thiopentone and propofol. Anaesthesia. 1985;40:735-740.
19. Edwards JP, Green RS. Post intubation hypotension: incidence, risk factors and outcomes [abstract]. Can J Emerg Med. 2006;8;210.
20. Edwards JP, Green RS. Severe hypotension following endotracheal intubation [abstract]. Can J Emerg Med. 2006;8:210-211.
21. Green RS. Etomidate and RSI: how important is post intubation hypotension? [letter]. Can J Emerg Med. 2007;9:3-4.
22. Kettler D, Sonntag H, Donath U, et al. Hemodynamics, myocardial mechanics, oxygen requirements, and oxygen consumption of the heart during induction of anaesthesia with etomidate. Anaesthesist. 1974;23:116-121.
23. Gooding JM, Corssen G. Effect of etomidate on the cardiovascular system. Anesth Analg. 1977;56:717-719.
24. Gooding JM, Weng J, Smith RA, et al. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg. 1979;58:40-41.
25. Sokolove PE, Price DD, Okada P. The safety of etomidate for emergency rapid sequence intubation of pediatric patients. Pediatr Emerg Care. 2000;16:18-21.
26. Swanson ER, Fosnocht DE, Neff RJ. The use of etomidate for rapid-sequence intubation in the air medical setting. Prehosp Emerg Care. 2001;5:142-146.
27. Choi YF, Wong TW, Lau CC. Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emerg Med J. 2004;21:700-702.
28. Plewa MC, King R, Johnson D, et al. Etomidate use during emergency intubation of trauma patients. Am J Emerg Med. 1997;15:98-99.
29. Swanson ER, Fosnocht DE, Jensen SC. Comparison of etomidate and midazolam for prehospital rapid-sequence intubation. Prehosp Emerg Care. 2004;8:273-279.
30. Prior JG, Hinds CJ, Williams J, et al. The use of etomidate in the management of severe head injury. Intensive Care Med. 1983;9:313-320.
31. Moss E, Powell D, Gibson RM, et al. Effect of etomidate on intracranial pressure and cerebral perfusion pressure. Br J Anaesth. 1979;51:347-351.
32. Schule am Esch J, Pfeifer G, Thiemig I. Effects of etomidate and thiopentone on the primarily elevated intracranial pressure (ICP). Anaesthesist. 1978;27:71-75.
33. Renou AM, Vernhiet J, Macrez P, et al. Cerebral blood flow and metabolism during etomidate anaesthesia in man. Br J Anaesth. 1978;50:1047-1051.
34. Patel PM, Goskowicz RL, Drummond JC, et al. Etomidate reduces ischemia-induced glutamate release in the hippocampus in rats subjected to incomplete forebrain ischemia. Anesth Analg. 1995;80:939.
35. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care: Guidelines for Management of Severe Head Injury. New York, NY: Brain Trauma Foundation; 1995.
36. Cold GE, Eskesen V, Eriksen H, et al. CBF and CMRO2 during continuous etomidate infusion supplemented with N2O and fentanyl in patients with supratentorial cerebral tumor: a dose response study. Acta Anaesthesiol Scand. 1985;29:490-494.
37. Laughlin TP, Newberg LA. Prolonged myoclonus after etomidate anesthesia. Anesth Analg. 1985;64:80-82.
38. Doenicke AW, Roizen MF, Kugler J, et al. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113-119.
39. Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology. 1984;61:616-618.
40. Modica PA, Tempelhoff R. Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression. Can J Anaesth. 1992;39:236-241.
41. Tobias JD. Etomidate: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2000;1:100-106.
42. Zaloga GP. Diagnosis and treatment of adrenal insufficiency during septic shock [letter]. Crit Care Med. 2003;31:2252-2253.
43. Schenarts CL, Burton JH, Riker RR. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med. 2001;8:1-7.
44. Lundy JB, Slane ML, Frizzi JD. Acute adrenal insufficiency after a single dose of etomidate. J Intensive Care Med. 2007;22:111-117.
45. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet. 1991;337:582-583.
46. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283:1038-1045.
47. Jackson WL. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? Chest. 2005;127:1031-1038.
48. Morris C. Etomidate for emergency anaesthesia: mad, bad and dangerous to know? Anaesthesia. 2005;60:737-740.
49. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia. 1999;54:861-867.
50. Pizarro C, Troster EJ, Damiani D, et al. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. 2005;33:855-859.
51. Murray H, Marik PE. Etomidate for endotracheal intubation in sepsis: acknowledging the good while accepting the bad. Chest. 2005;127:707-709.
52. Zed PJ, Mabasa VH, Slavik RS, et al. Etomidate for rapid sequence intubation in the emergency department: is adrenal suppression a concern? Can J Emerg Med. 2006;8:347-350.
53. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
54. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111-124.
55. Ray DC, McKeown DW. Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Critical Care. 2007;11:R56.
56. Walls RM. Special report: should etomidate be used as an induction agent for patients with sepsis? J Watch Emerg Med. 2008;2008:5-5.
57. Mendez DR, Goto CS, Abramo TJ, et al. Safety and efficacy of rocuronium for controlled intubation with paralytics in the pediatric emergency department. Pediatr Emerg Care. 2001;17:233-236.
58. McAllister JD, Gnauck KA. Rapid sequence intubation of the pediatric patient. Pediatr Clin North Am. 1999;46:1249-1284.
59. Boulanger A, Hardy JF, Lepage Y. Rapid induction sequence with vecuronium: should we intubate after 60 or 90 seconds? Can J Anaesth. 1990;37:296-300.
60. Cooper RA, Mirakhur RK, Maddineni VR. Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia. Anaesthesia. 1993;48:103-105.
61. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine and vecuronium for rapid-sequence induction of anesthesia in adult patients [abstract]. Anesthesiology. 1993;79:913.
62. Gerardi MJ, Sacchetti AD, Cantor RM, et al. Rapid sequence intubation of the pediatric patient. Ann Emerg Med. 1996:28:55-74.
63. Sakles JC, Laurin EG, Rantapaa AA, et al. Rocuronium for rapid sequence intubation of emergency department patients. J Emerg Med. 1999;17:611-616.
64. Laurin EG, Sakles JC, Panacek EA, et al. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000;7:1362-1369.
65. McCourt KC, Salmela L, Mirakhur RK, et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia. 1998;53:867-871.
66. Weiss JH, Gratz I, Goldberg ME, et al. Double-blind comparison of two doses of rocuronium and succinylcholine for rapid-sequence intubation. J Clin Anesth. 1997;9:379-382.
67. Andrews JI, Kumar N, van den Brom RH, et al. A large simple randomized trial of rocuronium versus succinylcholine in rapid-sequence induction of anaesthesia along with propofol. Acta Anaesth Scand. 1999;43:4-8.
68. Perry J, Lee J, Wells G. Rocuronium versus succinylcholine for rapid-sequence induction intubation. Cochrane. 2007;4:1-50.
69. Dobson AP, McCluskey A, Meakin G, et al. Effective time to satisfactory intubation conditions after administration of rocuronium in adults. Comparison of propofol and thiopentone for rapid sequence induction of anaesthesia. Anaesthesia. 1999;54:172-176.
70. Goldberg ME, Larijani GE, Azad SS, et al. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients. Anesth Analg. 1989;69:93-99.
71. Stoddart PA, Mather SJ. Onset of neuromuscular blockade and intubating conditions one minute after the administration of rocuronium in children. Paediatr Anaesth. 1998;8:37-40.
72. Fuchs-Buder T, Tassonyi E. Intubating conditions and time course of rocuronium-induced neuromuscular block in children. Br J Anaesth. 1996;77:335-338.
73. Naguib M, Samarkandi AH, Ammar A, et al. Comparison of suxamethonium an different combinations of rocuronium and mivacurium for rapid tracheal intubation in children. Br J Anaesth. 1997;79:450-455.
74. Vuksanaj D, Fisher DM. Pharmacokinetics of rocuronium in children aged 4-11 years. Anesthesiology. 1995;82:1104-1110.
75. Szenohradszky J, Fisher DM, Segredo V, et al. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology. 1992;77:899-904.
76. Bevan DR, Bevan JC, Donati F. Muscle Relaxants in Clinical Anesthesia. Chicago, IL: Year Book Medical Publishers; 1988;350.
77. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth Intensive Care. 1990;18:440-448.
78. Cook DR. Neuromuscular blocking agents. In: Fuhrman BP, Zimmerman JS, eds. Pediatric Critical Care. Philadelphia, PA: Mosby-Year Book Inc; 1992:1251-1263.
79. Kalli I, Meretoja OA. Duration of action of vecuronium in infants and children anaesthetized without potent inhalation agents. Acta Anaesthesiol Scand. 1989;33:29-33.
80. Fisher DM, Castagnoli K, Miller RD. Vecuronium kinetics and dynamics in anesthetized infants and children. Clin Pharmacol Ther. 1985;37:402-406.
81. Gronert BJ, Brandom BW. Neuromuscular blocking drugs in infants and children [abstract]. Pediatr Clin North Am. 1994;41:73.
82. Han TH, Kim HS, Bae JY, et al. Neuromuscular pharmacodynamics of rocuronium in patients with major burns. Anesth Analg. 2004;99:386-392.
83. Wierda JMKH, De Wit AP, Kuizenga K, et al. Clinical observations on the neuromuscular blocking action of Org 9426: a new steroidal non-depolarizing agent. Br J Anaesth. 1990;64:521-523.
84. McCoy EP, Maddineni VR, Elliott P, et al. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium. Can J Anaesth. 1993;40:703-708.
85. Skinner HJ, Biswas A, Mahajan RP. Evaluation of intubating conditions with rocuronium and either propofol or etomidate for rapid sequence induction. Anaesthesia. 1998;53:702-710.